A股異動 | 吉林化纖(000420.SZ)漲超6% 擬1.37億元收購吉林寶旌31%股權
格隆匯9月30日丨吉林化纖(000420.SZ)股價反彈回升,現報4.64元,漲幅6.18%,最新總市值100.6億;該股此前錄得4連陰,累計跌幅逾18%。公司29日公吿稱,擬1.37億元收購吉林寶旌31%股權,後者主要從事25K~50K大絲束、低成本碳纖維的研發、生產、銷售,當前具備年產8000噸碳纖維能力。此次交易有利於公司核心競爭力的提升,對公司未來經營業績產生積極的影響,有效增強公司持續盈利能力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.